iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report)’s share price fell 0.1% during mid-day trading on Thursday . The stock traded as low as $21.79 and last traded at $21.90. 86,270 shares changed hands during mid-day trading, an increase of 161% from the average session volume of 33,077 shares. The stock had previously closed at $21.92.
iShares Genomics Immunology and Healthcare ETF Stock Performance
The firm has a 50 day moving average of $23.50 and a 200-day moving average of $24.06. The stock has a market capitalization of $128.12 million, a PE ratio of 2.29 and a beta of 1.14.
Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF
An institutional investor recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC acquired a new stake in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned approximately 0.16% of iShares Genomics Immunology and Healthcare ETF as of its most recent filing with the Securities & Exchange Commission.
About iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
Recommended Stories
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- Expert Stock Trading Psychology Tips
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Following Congress Stock Trades
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.